We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Bm8.0
Bitter Melon Research
Likely helpsModerate safety
45 peer-reviewed studies
What the evidence says
Likely helps
Bitter Melon appears to help in 4 of 5 studies with measurable effects — the evidence leans clearly favourable.
Most evidence is from high-quality meta-analyses and randomised trials published 2006–2026 with a typical study size of 70 participants.
Based on 45 studies · 6 meta-analyses · 13 RCTs · 5,552 total participants
Confidence
High
What the studies found
4helped1unclear· 40 more without graded effect data
By outcome
Glucose & metabolicModest improvements in fasting glucose and insulin sensitivity · 8-12 weeks
Likely helps43 studies
Weight management
Mostly mechanism / observational8 studies
Safety profile
Mostly mechanism / observational6 studies
Therapeutic & clinical
Mostly mechanism / observational4 studies
Heart & blood pressure
Too few graded studies2 studies
Cholesterol & lipids
Too few graded studies1 study
By the numbers
Pulled from 30 studies with measurable effects
Likely real effects
63%
across studies
People studied
5,552
typical study: 70 people
Strongest designs
19
6 pooled, 13 randomised
Showed benefit
80%
4/5 studies
How long studies ran
1–4 weeks
1
1–3 months
5
3+ months
1
Populations Studied
Not specified4
Diabetes patients3
Patients with type 2 diabetes2
Type 2 diabetes mellitus patients2
Active research area
23 studies in the last 5 years · Latest meta-analysis: 2024
200620162026
1Meta-Analysisn=448 · medium study2024
There was no significant impact of bitter melon supplementation on BW, BMI, WC, and PBF.
Zou Y et al. · Prostaglandins & other lipid mediators (2024)
There was no significant impact of bitter melon supplementation on BW, BMI, WC, and PBF.
More large-scale and high-quality RCTs are necessary to confirm these results.
3Diabetes and prediabetes managementSystematic ReviewCited 4×2024
Phytotherapy Research
Derosa G et al. · Phytotherapy research : PTR (2024)
Further studies are also required for Cinnamomum, Cynara scolymus, Momordica charantia, Olea europaea, and Opuntia streptacantha.
Moreover, well-designed large and long-term clinical trials including the use of standardized nutraceutical preparations are necessary for Phaseolus vulgaris and Vaccinium myrtillus.
4Neurological disease management and memory improvementSystematic ReviewCited 1×2024
Furthermore, this substance can lower serum cholesterol and has multi-target activity in AD and memory loss.
Adarmanabadi SMHH et al. · Journal of integrative neuroscience (2024)
Furthermore, this substance can lower serum cholesterol and has multi-target activity in AD and memory loss.
M. charantia can also improve memory by decreasing tau protein and it also has potent antioxidant activity and anti-inflammatory effects.
This review highlights that M. charantia has effects on many age-related neurological disorders, and can be a cost-effective supplement with minimal side effects.
5Glucose homeostasis and body weight controlSystematic ReviewCited 2×2023
Both in vivo and in vitro studies are required to understand the mechanism of action of these plant extracts regarding insulin secretion to be used as a possible treatment for type 2 diabetes and body weight control in the future.
Torres-Vanda M et al. · Nutrients (2023)
Both in vivo and in vitro studies are required to understand the mechanism of action of these plant extracts regarding insulin secretion to be used as a possible treatment for type 2 diabetes and body weight control in the future.
This review paper aims at addressing this knowledge gap by studying DM and highlighting the biomedical significance of the most potent medicinal plants and vitamins with hypoglycemic properties that show a great potential to prevent and/or treat DM.
Yedjou CG et al. · International journal of molecular sciences (2023)
Results of numerous scientific investigations revealed that phytochemicals present in medicinal plants (Allium sativum, Momordica charantia, Hibiscus sabdariffa L., and Zingiber officinale) possess anti-hypoglycemic activities and show promise for the prevention and/or control of DM.
Results also revealed that intake of vitamins C, D, E, or their combination improves the health of diabetes patients by reducing blood glucose, inflammation, lipid peroxidation, and blood pressure levels.
However, very limited studies have addressed the health benefits of medicinal plants and vitamins as chemo-therapeutic/preventive agents for the management of DM.
7Breast and gynecological cancer prevention and therapySystematic ReviewCited 8×2023
The current work constitutes the most comprehensive, up-to-date review of the literature, which highlights the promising anticancer effects of bitter melon on breast, ovarian, and cervical cancer cells and discusses future research recommendations.
Psilopatis I et al. · International journal of molecular sciences (2023)
Phytotherapy has long represented a widely accepted treatment alternative to conventional therapy.
Bitter melon is a vine with potent antitumor effects against numerous cancer entities.
To date, no review article has, however, been published on the role of bitter melon in breast and gynecological cancer prevention and therapy.
8COVID-19 management and antiviral effectsSystematic ReviewCited 21×n=36 · small study2021
The study identified some important potential traditional Indian medicinal herbs such as Ocimum tenuiflorum, Tinospora cordifolia, Achyranthes bidentata, Cinnamomum cassia, Cydonia oblonga, Embelin ribes, Justicia adhatoda, Momordica charantia, Withania somnifera, Zingiber officinale, Camphor, and Kabusura kudineer, which could be used in therapeutic strategies against SARS-CoV-2 infection.
Singh RS et al. · Phytotherapy research : PTR (2021)
A total of 22 relevant traditional Indian medicinal plants (35 relevant studies) were included in the current study having potential antiviral properties against virus-induced respiratory illness along with promising immunomodulatory and thrombolytic properties.
Further, 36 randomized and nonrandomized registered clinical trials were also included that were aimed at evaluating the efficacy of herbal plants or their formulations in COVID-19 management.
International Wound Journal published by Medicalhelplines.com Inc and John Wiley & Sons Ltd.
Zamanifard M et al. · International wound journal (2024)
Noticeable benefit
← WorseNo effectBetter →
Likely real
Also, daily use of the bitter melon leaf extract in oral form for 28 days significantly increased the total ulcer healing score (2 RCTs; WMD = 0.40; p = 0.001).
Additionally, based on qualitative synthesis, the adjuvant use of herbal agents seems an intriguing choice to manage DFU.
Nonetheless, considering the undesirable methodological quality of most studies and the high heterogeneity in administered herbal formulations, more robust trials are required to build a solid conclusion regarding the use of herbal products for healing DFU.
11Hypoglycemic and hypolipidemic effects through gut health modulationSystematic ReviewCited 7×2024
As a result, this review will serve as a theoretical basis for potential applications in the creation or modification of MC-based nutrient supplements.
Xiao X et al. · Journal of medicinal food (2024)
This review offers an up-to-date overview of the recently reported chemical compositions of MC, including polysaccharides, saponins, polyphenolics, peptides, and their beneficial effects.
It also provides the latest updates on the role of MC in the regulation of gut microbiota and bitter taste receptor signaling pathways.
As a result, this review will serve as a theoretical basis for potential applications in the creation or modification of MC-based nutrient supplements.
12Hypoglycemic effects in diabetes mellitusSystematic ReviewCited 35×2022
Moreover, the clinical application of M. charantia in treating diabetes mellitus is also discussed, hoping to broaden the application of M. charantia as functional food.
Xu B et al. · Molecules (Basel, Switzerland) (2022)
Functional ingredients of M. charantia play important roles in body health and human nutrition, which can be used directly or indirectly in treating or preventing hyperglycemia-related chronic diseases in humans.
The hypoglycemic effects of M. charantia have been known for years.
In this paper, the research progress of M. charantia phytobioactives and their hypoglycemic effects and related mechanisms, especially relating to diabetes mellitus, has been reviewed.
13Bitter Melon efficacy in diabetes therapySystematic ReviewCited 13×2021
Thus, we speculate that the Clinical Pharmacology should explore the field of plant-based compounds that will keep concentrating the attention of researchers, and therefore, we gathered studies in advanced stages that highlight the role of plants in the diabetes therapy.
Marmitt DJ et al. · Expert review of clinical pharmacology (2021)
15Metabolic effects on diabetes, lipids, and obesitySystematic ReviewCited 8×2021
This study aims to review the metabolic effects of MC reported in clinical trials as well as its mechanisms of action.
Cortez-Navarrete M et al. · Journal of medicinal food (2021)
The search for safe and effective complementary and alternative therapies to treat metabolic disorders is a key field of research.
Momordica charantia (MC) is a tropical and subtropical vine of the Cucurbitaceae family used as a medicinal plant since ancient times.
Although MC has been widely studied for its hypoglycemic potential, hypolipidemic and antiobesity effects have also been reported in preclinical studies and clinical trials.
Fang EF et al. · Current protein & peptide science (2019)
Bitter melon or bitter gourd (Momordica charantia) is a common vegetable in Asia and it is distinctive for its bitter taste.
As an ingredient in folk medicine, research from different laboratories in recent years supports its potential medicinal applications with anti-tumor, anti-diabetic, anti-HIV activities in both in vitro and animal studies.
In this short review, we summarize herein the recent progress in the antitumor aspect of bitter melon with a focus on the underlying molecular mechanisms.
M. charantia adjunct preparations improved glycemic control in T2DM patients.
Peter EL et al. · Journal of ethnopharmacology (2019)
M. charantia adjunct preparations improved glycemic control in T2DM patients.
However, this conclusion is based on low to very low quality evidences for the primary outcomes and sparse data for several safety outcomes, thus, warrant further research.
Although further research is necessary to explore various issues, this review establishes the therapeutic potential of M. charantia and it is highly promising candidate for the development of anti-obesity health products and medicines.
Fan M et al. · International journal of environmental research and public health (2019)
The major bioactive components that showed anti-obesity activities included proteins, triterpenoids, saponins, phenolics, and conjugated linolenic acids.
Their mechanisms included inhibition of fat synthesis, promotion of glucose utilization, and stimulation of auxiliary lipid-lowering activity.
Finally, we summarized the risks of excessive consumption of M. charantia and the application.